Genzyme and Relational Investors: Science and Business Collide?

Case Solution

This Case is about FINANCIAL MANAGEMENT

PUBLICATION DATE: December 02, 2011 PRODUCT #: UV6529-PDF-ENG

The chairman and CEO of the Genzyme Corporation, one the nation’s top five biotechnology companies, has received a phone call requesting a meeting with all the cofounder and principal of a big hedge fund that now has a 2.6% stake in his business. Before a meeting with him, the CEO knows that he needs a strategy for coping with this “activist” investor using a reputation for forcing out CEOs.